more_reports

Streetwise Articles



billionaires gold

Billionaires Buying Gold Bullish for the Yellow Metal
Source: Deborah Baratz, Money Morning  (11/21/12)
Gold buying by some of the world's most successful investors is a strong argument that gold prices, despite their impressive rise over the past several years, still have a long way to go. More >


Gareth Hatch

Gareth Hatch: Supply Chain Economics Drive Rare Earths Stocks
Source: Brian Sylvester of The Critical Metals Report  (11/20/12)
There are few mining sectors where chemistry, metallurgy and the supply chain meet in such a complex yet potentially profitable way as rare earths. Companies must keep an eye perpetually toward the future, making prescient judgments about end-user demands and constantly evolving technologies. In this interview with The Critical Metals Report, Gareth Hatch, founding principal of Technology Metals Research and president and director of Innovation Metals Corp., gives an update about which projects are closest to production and which have the right recipe to entice customers. More >


Keystone XL

Keystone Oil Pipeline Decision Key to Obama's Energy Policy
Source: Tony Daltorio, Money Morning  (11/20/12)
"The U.S. State Department, which is ruling on the project, is currently conducting another environmental assessment on the Keystone oil pipeline project. This assessment will be concluded by the summer of 2013." More >


Michael Berry

Michael Berry Applies His 10 Discovery Investing Factors to Biotech
Source: George S. Mack of The Life Sciences Report  (11/20/12)
Discovering how and why a famed natural resource investor would begin to apply himself vigorously to biotechnology stocks is fascinating. Take Michael Berry, founder and managing director of Discovery Investing, for example. Berry doesn't shy away from high-risk biotech plays because he loves the feel of hitting a grand slam right out of the park, even if that doesn't happen often. Berry brings his expertise toThe Life Sciences Report in this interview, sharing his best ideas and describing how he applies his Ten Discovery Investing Factors to some very sophisticated biotech companies. More >


Kenny Feng

What Every Investor Should Know About Income and Growth: Kenny Feng
Source: George S. Mack of The Energy Report  (11/20/12)
More and more investors are catching on to the steady returns and market resilience that master limited partnerships (MLPs) have historically offered. And when MLP investors evaluate sector performance, they frequently use the Alerian MLP index as their benchmark of choice. Alerian maintains the standard indices for MLPs, and in this Energy Report interview, the company's president and CEO, Kenny Feng, explores some of the issues vital to income- and growth-seeking investors. More >


When I Saw This Bionic Skin, All I Could Say Was 'Wow'
Source: Michael Robinson, Money Morning  (11/20/12)
"The potential for products--and profits--is tremendous. We're talking applications in medicine, electronics, construction and even aircraft." More >


The Energy Upside of the Fiscal Cliff
Source: Kent Moors, Oil & Energy Investor  (11/20/12)
"A pronounced move down in the market usually results in energy share prices falling faster. But when the recovery occurs, energy leads shares up." More >


Designing the World’s First Floating LNG Export Terminal
Source: Keith Schaefer, Oil & Gas Investments Bulletin  (11/20/12)
"It looks like the little guy is going to be the first out of the gate." More >


The Long and the Short of DNA Sequencing
Source: Patricia Dimond, Genetic Engineering and Biotechnology News  (11/20/12)
"With advances in second-generation sequencing technologies, genome studies have produced an explosion of sequence data at a fraction of earlier costs." More >


Jocelyn August

The ABCs of Mining Catalysts: Jocelyn August
Source: George S. Mack of The Gold Report  (11/19/12)
Investors need to know their catalysts and their potential effects—good and bad—on precious metals mining companies. Jocelyn August, senior analyst at Sagient Research, knows her catalysts from pre-exploration to production. In this Gold Report interview, she describes eight catalysts and gives examples of upcoming catalysts for seven small-cap companies. More >


Shwedagon pagoda

Golden Opportunities in Myanmar
Source: Frank Holmes, Frank Talk  (11/19/12)
"The country has been called 'probably the best investment opportunity in the world right now.'" More >


High Gold Prices Push Many Indians to Silver for Diwali
Source: Shivom Seth, Mineweb  (11/19/12)
"The stable price of silver has Indians investing in the white metal, with investors looking for good returns." More >


Charlie  Brookes

Three Points a Jurisdiction Must Meet Before You Invest: Charlie Brookes
Source: Brian Sylvester of The Gold Report  (11/19/12)
With money rushing out of the junior resource space, Charlie Brookes, investment director at Arlington Group Asset Management and investment manager at Praetorian Resources, is rushing in—thoughtfully. In this Gold Report interview, he says now is the time to buy and hold, but it is crucial that investors do their homework before investing. More >


monopoly

Does China Really Want a Rare Earth Monopoly?
Source: Hongpo Shen, ProEdge Wire  (11/19/12)
"China's rare earth White Paper notes that China 'hopes countries and regions with abundant REE reserves will make active efforts in developing their own resources.'" More >


Breakthrough Nanoparticle Halts Multiple Sclerosis in Mice, Offers Hope for Other Immune-Related Diseases
Source: Science Daily  (11/18/12)
"Nanoparticles have many advantages. They can be readily produced in a laboratory and standardized for manufacturing. They would make the potential therapy cheaper and more accessible to a general population." More >


onering2

One (Biotech) Ring to Rule Them All
Source: John Mauldin, Investor Insight.com; Patrick Cox, Breakthrough Technology Alert  (11/17/12)
"We are just at the beginning of a biotech revolution that will astound and amaze. Enough said." More >


John Mauldin

John Mauldin's Roadmap to Surviving the Fiscal Cliff
Source: JT Long of The Gold Report  (11/16/12)
Investors could be in for a bumpy ride the rest of the year as politicians navigate a difficult path toward a solution to what is being billed as the fiscal cliff of $720 billion in expiring tax cuts and mandatory spending cuts. In this interview with The Gold Report, John Mauldin, author of Thoughts from the Frontline, shares his insights on some of the possible twists and turns ahead and how investors can brace themselves for whatever comes. More >


relative gold

Gold's Relative Strength and What It Means
Source: Jordan Roy-Byrne, The Daily Gold  (11/16/12)
"Gold is in a healthy bullish position because it's trending higher against all major markets with the exception of bonds." More >


A Change Is Coming: 2013 & Onward, Part I
Source: Julian Phillips, Gold Forecaster  (11/16/12)
"The shift of wealth from the West to the East is a long-term facet of the global economy." More >


Gold Up, Gold Stocks Get Pummeled
Source: Bob Kirtley, SK Options Trading  (11/16/12)
"It is possible that gold mining stocks are being classified as general stocks so when the market sells off, the mining stocks are also sold off." More >


James West

James West Sees Catalysts in the Energy Sector
Source: The Energy Report Editors  (11/15/12)
As we head into the last quarter of the year, James West questions how important macroeconomic trends are for individual investors. But he does believe stock catalysts in the energy space are easier to understand than precious metals market forces. In this interview with The Energy Report, West updates us on some possible top performers in the space and what they're doing right. More >


US energy independence

The Rocky Path to US Energy Independence
Source: Kent Moors, Oil & Energy Investor  (11/15/12)
"Before you decide to declare 'energy independence,' take a look at some of the downside that may come with it." More >


Getting Cancer Immunotherapeutics Approved
Source: Patricia Dimond, Genetic Engineering and Biotechnology News  (11/15/12)
"While biologically based therapeutic cancer vaccines and other cancer immunotherapies have great promise in treating certain cancers, getting to 'yes' for FDA approval is likely to remain challenging." More >


Kenya Urges Oil Producers to Collaborate
Source: Jacinta Moran, Platts  (11/15/12)
"Kenya wants countries in the region to increase collaboration in infrastructure development and financing in order to bring newly discovered resources to market." More >


Hugh Cleland

Applying the Venture Capital Model to Public Companies: Hugh Cleland
Source: George S. Mack of The Life Sciences Report   (11/15/12)
Hugh Cleland has been testing his theory that life sciences companies can be had cheaper as stocks than as private venture capital investments—and that theory has been working out for him quite well over the past two years. In this interview with The Life Sciences Report, Cleland, portfolio manager and executive vice president at Toronto-based BluMont Capital, talks about his best small- and micro-cap ideas and also shares the "core/farm team" approach that he takes in his smaller, more conventionally structured fund. More >


Showing Results: 12751 to 12775 of 25198 Prev Next

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe